To further investigate whether the mRNA expression levels of MIAT exhibit changes in breast cancer, we utilized breast cancer cDNA arrays (BCRT101, BCRT102, and BCRT104) from OriGene Inc and determined MIAT expression levels in breast cancer and normal tissues. The gene discussed is MIAT; the disease is breast cancer.